Pacira Hits Rivals With False Ad Suits Over Pain Drugs
By Jonathan Capriel · November 3, 2023, 7:53 PM EDT
Pharmaceutical company Pacira BioSciences Inc. is looking to stop rivals from marketing their so-called generic versions of its non-opioid based drug used to manage post-surgery pain, claiming in three separate lawsuits...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login